Does Keto Prevent Muscle Loss on Weight-Loss Injections?

Short answer: no, not in the sense that going keto automatically protects your muscle. A meaningful share of the weight lost on semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro) comes from muscle tissue, and what decides how much is not your carbohydrate intake but your protein intake and whether you do resistance training. Two large meta-analyses and a cohort study published in 2025 made that picture fairly clear. Keto does have a role here, just not the one most people assume.

How Big Is the Muscle Loss Problem With Weight-Loss Injections?

Interest in weight-loss injections has never been higher, and a large share of people using them are also experimenting with keto or low-carb eating, on the logic that combining the two will bring faster, more lasting results. What gets missed is that not all the weight these drugs remove is fat.

A meta-analysis published in Obesity pooled 9 randomized controlled trials of exenatide, liraglutide, semaglutide and tirzepatide (659 participants total, 419 on active drug) using DXA scans, and found that lean mass made up 30.8% of the total weight lost by people on the medication. The same month, a separate meta-analysis in Metabolism Clinical and Experimental covering 22 trials and 2258 participants found that lean mass accounted for about 25% of total weight loss, an effect that was significant for every drug studied except liraglutide.

Does Keto Stop This Muscle Loss?

There's a common mix-up here. Many people hear "keto" and picture a high-protein diet, but classic ketogenic eating gets most of its calories from fat, with protein usually kept moderate. What protects muscle is not how low your carbohydrate is — it's whether your protein is adequate. Cut carbohydrate while keeping protein low, and you gain no advantage at all on the muscle-loss front.

Data supporting this came out of the Endocrine Society's 2025 annual meeting (ENDO 2025, San Francisco). A team led by researcher Melanie Haines compared 23 people on semaglutide with 17 following a lifestyle program over three months. Muscle loss in the semaglutide group was notably greater among older participants, women, and those eating less protein. Haines' point was direct: losing too much muscle on a weight-loss injection also blunts the drug's benefit for blood sugar control.

Can Protein and Exercise Actually Protect Muscle?

The clearest answer so far comes from a cohort study presented at the European Congress on Obesity in Malaga in May 2025. Two hundred adults (ages 18-65, more than half women) on semaglutide or tirzepatide were educated about GLP-1 drugs and coached to eat enough protein and do resistance training. After six months, women lost an average of 12% of body weight and men 13%; most of that came from fat, while muscle loss stayed comparatively small — roughly 0.6 kilograms in women and 1.1 kilograms in men.

Set against the 25-30% figures from the meta-analyses above, the contrast is striking: in a group coached on protein and training, muscle made up a far smaller share of what was lost. The two sets of studies aren't directly comparable, so it would be a stretch to credit the entire gap to protein and exercise alone. To test this more rigorously, a randomized trial of 232 people (LEAN-PREP) is currently underway, and its results should be the strongest evidence yet on this question.

What to Watch for When Combining Keto With a Weight-Loss Injection

• Appetite suppression stacks. Both GLP-1 drugs and ketosis reduce appetite. Combined, it's easy to drop well below your protein and calorie targets without noticing, which can accelerate muscle loss. Planning small, protein-forward meals works better than skipping meals altogether.
• Digestive side effects can overlap. Nausea, early fullness and constipation are common with both. Easing into keto gradually, and getting enough fluids and electrolytes, matters even more during this period; our electrolyte balance article covers how to set that up.
• Diabetes medication may need adjusting. If you're on insulin or a sulfonylurea, dropping carbohydrate quickly raises the risk of hypoglycemia. If you take an SGLT2 inhibitor (such as empagliflozin or dapagliflozin), a very low-carbohydrate diet can raise the risk of a rare but serious condition called euglycemic diabetic ketoacidosis — don't try this combination without medical sign-off.
• Gallbladder risk rises from both directions. Rapid weight loss and GLP-1 drugs each independently raise the risk of gallstones. Together, that risk shouldn't be ignored, especially if you've had gallbladder issues before.

In Practice: A Protein-First Approach

The general recommendation in the nutrition literature for preserving muscle during weight loss is about 1.2 to 1.6 grams of protein per kilogram of body weight. With appetite already suppressed by a weight-loss injection, hitting that target can be harder than usual, so it helps to put your protein source — eggs, cheese, chicken, fish, meat — on the plate first and build the fat around it, rather than filling out calories with fat-heavy snacks. On top of that, resistance training at least twice a week — weights, bodyweight work, or resistance bands — was the factor most consistently linked to muscle preservation in the studies above. We cover where to start with the exercise side in our exercise on keto article.

What These Studies Don't Show

• The two meta-analyses pool different sets of trials. The Obesity analysis covers 9 trials, the Metabolism Clinical and Experimental one covers 22, spanning different drugs, durations and measurement methods. The percentages landing close together is reassuring, but these aren't the same dataset.
• The ECO 2025 cohort wasn't randomized. All 200 participants received protein and exercise coaching; there was no control group that received none. So crediting the entire reduction in muscle loss to protein and exercise is premature — participants who sign up for this kind of coaching may also simply be more motivated, which could skew the result.
• Six months is a short follow-up. Weight-loss injections are typically used for years. We don't have enough data on how muscle loss plays out at the one- or two-year mark.
• No study has directly tested "the keto diet" itself. All the evidence here concerns protein amount and resistance training; no randomized trial has tested a ketogenic diet specifically alongside GLP-1 drugs. Keto's apparent benefit comes from making it easier to hit a protein target when well formulated, not from ketosis itself.

Should You Stay on Keto After Stopping the Injection?

One fact shapes the answer here: when a weight-loss injection is stopped, most of the weight tends to come back. In the extension phase of the STEP 1 trial, which tracked 68 weeks of semaglutide use, participants lost an average of 17.3% of body weight during that period; a year after stopping the drug, they had regained 11.6 percentage points of it, leaving a net loss of just 5.6%. In other words, a large share of the weight lost comes back once the medication stops.

This is the real reason many people turn to keto as something to fall back on after stopping the injection — it's a reasonable instinct, but it needs a clear caveat: no study has specifically tested keto as a maintenance strategy after discontinuing a GLP-1 drug. What we have is older, more general literature suggesting low-carbohydrate eating tends to increase satiety. Having an eating pattern in place to fill the appetite gap the drug leaves behind is a sensible strategy, but calling it a guaranteed fix would be getting ahead of the evidence.

Who Should Not Start Without a Doctor

If you're on a weight-loss injection and considering keto, talk to your doctor first if any of the following applies:

• You take insulin, a sulfonylurea or an SGLT2 inhibitor.
• You've had gallstones or gallbladder inflammation before.
• You have a history of disordered eating; two overlapping appetite suppressants deserve extra caution here.
• You have kidney disease, are pregnant, or are breastfeeding.

For everyone else, checking blood sugar, kidney function and electrolytes before starting and again a few weeks in is the most concrete way to see whether the two approaches are working safely together for you.

Sources: Healio, "About 31% of weight lost by adults during GLP-1 therapy comes from lean mass" (March 2025), based on the Obesity meta-analysis · Karakasis et al., "Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis", Metabolism Clinical and Experimental (March 2025) · Endocrine Society, ENDO 2025 press release (Melanie Haines) · Healio, European Congress on Obesity 2025 cohort study coverage · LEAN-PREP study, ClinicalTrials.gov NCT06885736 · "Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension" (2022)